Industry Overview of Dialysis Market
Dialysis represents a renal replacement therapy that assists in eliminating salts, excess water, toxins, and solutes from the blood of the patient whose kidneys do not function naturally. It is a procedure for purifying the blood and restoring its electrolyte balance. Dialysis is of two major types, such as hemodialysis and peritoneal. Hemodialysis involves extra-corporeal blood cleansing, whereas peritoneal dialysis refers to the process of filtering the blood by using the peritoneum in the abdomen of the patient as the dialysis medium. This therapy is convenient, flexible, provides mobility, and has a better survival rate. As a result, dialysis finds widespread applications in kidney transplants, the treatment of acute renal injury and chronic kidney diseases, or as a permanent measure where a transplant is not advisable.
How Big Is the Dialysis Market?
The global dialysis market size reached US$ 110.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 148.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2023-2028.
Global Industry Trends and Drivers:
The rising number of diabetic and hypertension patients and the escalating incidences of end-stage renal disease (ESRD) are primarily driving the dialysis market. Besides this, the increasing cases of chronic kidney disease (CKD) that have propelled patients to opt for hemodialysis to enhance their health while reducing the chances of developing nerve damage are further augmenting the market growth. Moreover, the shifting preferences of individuals from kidney transplantation towards dialysis to reduce health complications and improve quality care are also catalyzing the global market. Apart from this, the inflating investments by the leading organizations in upgrading healthcare infrastructures and the extensive research and development (R&D) activities and clinical trials for treating CKD are acting as significant growth-inducing factors. Additionally, the launch of several policies by the government bodies to spread awareness toward maintaining kidney health and the easy accessibility to various renal treatment options are also stimulating the market growth. Furthermore, the introduction of sorbent-based regenerative technology that enables the delivery of high-dose therapy while removing toxins is expected to bolster the dialysis market in the coming years.
What Is Included In Market Segmentation?
The report has been segmented the market into following categories:
Breakup by Type:
• Hemodialysis
o Conventional Hemodialysis
o Short Daily Hemodialysis
o Nocturnal Hemodialysis
• Peritoneal Dialysis
o Continuous Ambulatory Peritoneal Dialysis (CAPD)
o Automated Peritoneal Dialysis (APD)
Breakup by Product and Services:
• Services
• Equipment
o Dialysis Machines
o Water Treatment Systems
o Others
• Consumables
o Dialyzers
o Catheters
o Others
• Dialysis Drugs
Breakup by End User:
• In-center Dialysis
• Home Dialysis
Breakup by Region:
• North America
o United States
o Canada
• Asia-Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others
• Latin America
o Brazil
o Mexico
o Others
• Middle East and Africa
The report provides a comprehensive analysis of the industry key players listed below:
Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, DaVita Inc., Fresenius Medical Care AG & Co. KGaA, JMS Co. Ltd., Medtronic plc, Nikkiso Co. Ltd., NIPRO Corporation, Satellite Healthcare Inc. and Toray Industries Inc.
